Effect | Decrease |
Trial Design | Double blind |
Trial Length | 6+ Months |
Number of Subjects | 60 |
Sex | Both Genders |
Age Range | 7-12, 13-17 |
Body Types | Obese, Overweight |
Study conducted in children with confirmed Non-alcoholic fatty liver disease treated with either 250 or 500mg DHA daily. Although there was a reduction in liver fat, the improvement in TGs and insulin sensitivity were similar between fish oil and placebo.